- Home
- TECH vs XPO Comparison
TECH vs XPO Comparison
Compare TECH & XPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- XPO
- Stock Information
- Founded
- TECH 1976
- XPO 2000
- Country
- TECH United States
- XPO United States
- Employees
- TECH N/A
- XPO N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- XPO Transportation Services
- Sector
- TECH Health Care
- XPO Consumer Discretionary
- Exchange
- TECH Nasdaq
- XPO Nasdaq
- Market Cap
- TECH 11.3B
- XPO 11.8B
- IPO Year
- TECH 1989
- XPO N/A
- Fundamental
- Price
- TECH $69.88
- XPO $150.54
- Analyst Decision
- TECH Buy
- XPO Strong Buy
- Analyst Count
- TECH 9
- XPO 16
- Target Price
- TECH $81.78
- XPO $141.13
- AVG Volume (30 Days)
- TECH 1.2M
- XPO 1.5M
- Earning Date
- TECH 10-30-2024
- XPO 10-30-2024
- Dividend Yield
- TECH 0.47%
- XPO N/A
- EPS Growth
- TECH N/A
- XPO 895.80
- EPS
- TECH 0.95
- XPO 3.08
- Revenue
- TECH $1,171,583,000.00
- XPO $8,090,000,000.00
- Revenue This Year
- TECH $7.67
- XPO $5.40
- Revenue Next Year
- TECH $9.38
- XPO $4.28
- P/E Ratio
- TECH $72.05
- XPO $47.31
- Revenue Growth
- TECH 2.41
- XPO 5.96
- 52 Week Low
- TECH $61.16
- XPO $78.72
- 52 Week High
- TECH $85.57
- XPO $156.85
- Technical
- Relative Strength Index (RSI)
- TECH 42.25
- XPO 69.06
- Support Level
- TECH $65.61
- XPO $142.78
- Resistance Level
- TECH $76.43
- XPO $156.85
- Average True Range (ATR)
- TECH 2.61
- XPO 4.09
- MACD
- TECH -0.72
- XPO -0.54
- Stochastic Oscillator
- TECH 23.30
- XPO 76.28
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About XPO XPO Inc.
Following the spinoff of its contract logistics division (GXO) in 2021 and freight brokerage operations (RXO) in 2022, XPO is moving closer to becoming a pure-play asset-based less-than-truckload carrier. On a pro forma basis for the RXO spinoff, We estimate LTL shipping now makes up 60% of total revenue, with XPO's European truckload and LTL operations making up 40%. However, XPO's LTL segment EBITDA mix is much higher than 60%. We believe XPO intends to divest its European trucking division once it finds the right buyer.